Positive Psychology to Improve Cardiac Health Behaviors
PEACE
Developing a Positive Psychology Intervention to Improve Cardiac Health Behaviors: Qualitative Research Phase
2 other identifiers
interventional
30
1 country
1
Brief Summary
The purpose of the study is to understand peoples' positive emotions, like how optimistic or grateful they feel, after they have had a heart problem. The investigators want to determine whether positive emotions affect peoples' ability to follow recommendations, like following a healthy diet, exercising, and taking medication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 4, 2013
CompletedFirst Posted
Study publicly available on registry
March 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedSeptember 16, 2014
September 1, 2014
5 months
March 4, 2013
September 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Deficits in positive affect
Qualitative data: The investigators will extract information from 2 quantitative interviews to learn about participants' deficits in positive affect. Quantitative data: Life Orientation Test-Revised, Positive And Negative Affect Scale, Hospital Anxiety and Depression Scale.
12 weeks
Barriers to health behaviors
Qualitative data: The investigators will extract information from 2 qualitative interviews to learn about participants' barriers to completing health behaviors. Quantitative data: Participants will receive a pill bottle that tracks when they take their aspirin. Participants will also receive a step counter to wear for two weeks.
12 weeks
Secondary Outcomes (1)
Changes in positive affect
Change from baseline positive affect at 12 weeks
Study Arms (2)
Optimal adherence
OTHERParticipants receive the qualitative interview and adherence intervention. This arm includes participants with scores of greater than or equal to 15 on the Medical Outcomes Study Specific Adherence Scale. This scale ranges from a score of 3 (extremely low adherence to health behaviors) to a score of 18 (extremely high adherence to health behaviors). A score of greater than or equal to 15 suggests optimal adherence to health behaviors.
Sub-optimal adherence
OTHERParticipants receive the qualitative interview and adherence intervention. This arm includes participants with scores of less than 15 on the Medical Outcomes Study Specific Adherence Scale. This scale ranges from a score of 3 (extremely low adherence to health behaviors) to a score of 18 (extremely high adherence to health behaviors). A score of less than 15 suggests sub-optimal adherence to health behaviors.
Interventions
All participants receive the same intervention. The intervention involves two qualitative interviews per participant. The first interview occurs in the hospital, and the second interview occurs at 12 weeks. Participants also receive a pill bottle that tracks when they take their aspirin. They will also receive a step counter to use for two weeks at the end of the study.
Eligibility Criteria
You may qualify if:
- Admission to Massachusetts General Hospital cardiac floors (Ellison 9, 10, 11)
- Age 18 or older
- Admitted with myocardial infarction or unstable angina
- Score of less than 15 --OR-- greater than or equal to 15 on the adherence scale
- Ability to read and write in English
You may not qualify if:
- Cognitive deficits as assessed by a 6-item screen
- Medical conditions that prevent interviewing or are likely to lead to death within 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff C Huffman, MD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director of Inpatient Psychiatric Unit
Study Record Dates
First Submitted
March 4, 2013
First Posted
March 8, 2013
Study Start
March 1, 2013
Primary Completion
August 1, 2013
Study Completion
December 1, 2013
Last Updated
September 16, 2014
Record last verified: 2014-09